Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Clarissa Lam"'
Autor:
Michelle L. Kuznicki, Maya Yasukawa, Adrianne R. Mallen, Clarissa Lam, Erica Eggers, Jefferson Regis, Ali Wells, Sarah L. Todd, Sharon E. Robertson, Jean-Paul Tanner, Matthew L. Anderson, Thomas J. Rutherford
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
ObjectiveThis study aims to evaluate the feasibility and safety of planned postoperative day 1 discharge (PPOD1) among patients who undergo laparotomy (XL) in the department of gynecology oncology utilizing a modified enhanced recovery after surgery
Externí odkaz:
https://doaj.org/article/dd74de624e9c431eb71a25e56842dd03
Publikováno v:
Gynecologic Oncology Reports, Vol 49, Iss , Pp 101258- (2023)
Combination therapy of lenvatinib, a multitargeted tyrosine kinase inhibitor (TKI), plus pembrolizumab, a monoclonal antibody targeting programmed death receptor 1 (PD-1), was recently approved by the Food and Drug Administration for therapy of advan
Externí odkaz:
https://doaj.org/article/d0db035ace3e438eb48633e9306b5b60
Autor:
Nicholas Adzibolosu, Ayesha B. Alvero, Rouba Ali-Fehmi, Radhika Gogoi, Logan Corey, Roslyn Tedja, Hussein Chehade, Vir Gogoi, Robert Morris, Matthew Anderson, Julie Vitko, Clarissa Lam, Douglas B. Craig, Sorin Draghici, Thomas Rutherford, Gil Mor
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionOvarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or la
Externí odkaz:
https://doaj.org/article/262a995315a3479982fcdcf6edad0ecd
Publikováno v:
Gynecologic Oncology Reports, Vol 41, Iss , Pp 100992- (2022)
Externí odkaz:
https://doaj.org/article/ebd3143997e241e78c33a9876ce0ba67
Publikováno v:
Journal of Gynecologic Surgery. 38:72-74
In this case, we discuss emergent small bowel resection and reanastomosis for a closed loop small bowel obstruction in the setting of recent bevacizumab exposure. Bevacizumab is a humanized monoclo...
Autor:
Sarah Ehmann, Clarissa Lam, Qin Zhou, Rachel Grisham, Kara Long Roche, Oliver Zivanovic, Yukio Sonoda, Dennis Chi, Ginger Gardner
Publikováno v:
Gynecologic Oncology. 166:S268
Publikováno v:
Gynecologic Oncology. 162:S98
Objectives: The objective of this retrospective review was to assess barriers to successful clinical trial enrollment among gynecologic cancer patients at a comprehensive cancer center. Methods: A retrospective chart review was performed of all new p
Publikováno v:
Obstetrics and gynecology. 134(1)
Background Hysterectomies are the most common benign gynecologic surgical procedures performed in the United States. Currently, there are no tissue models that exist to teach trainees the techniques for colpotomy during laparoscopic hysterectomy. To
Autor:
Clarissa Lam, Amitasrigowri Murthy
Publikováno v:
Open Access Journal of Contraception
In the US, obesity rates are increasing greatly. The Centers for Disease Control and Prevention estimates that 68.5% of Americans, including 63.9% of adult women older than 20 years, are overweight (body mass index between 25 kg/m2 and 29.9 kg/m2) or
Autor:
Alexandra Martin, Lauren C. Peres, Adrianne Mallen, Ali Wells, Jing-Yi Chern, Sweta Sinha, Clarissa Lam, Kathryn Cline
Publikováno v:
Journal of Clinical Oncology. 38:e18067-e18067
e18067 Background: Concern for toxicities in obese ovarian cancer patients may limit weight-based chemotherapy dosing, which has been associated with poor survival. We sought to evaluate the impact of obesity on treatment and outcomes by race/ethnici